Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Decision curve analysis: a novel method for evaluating prediction models.

Vickers AJ, Elkin EB.

Med Decis Making. 2006 Nov-Dec;26(6):565-74.

2.

Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.

Secin FP, Bianco FJ, Cronin A, Eastham JA, Scardino PT, Guillonneau B, Vickers AJ; European Society of Urologic Oncology.

J Urol. 2009 Feb;181(2):609-13; discussion 614. doi: 10.1016/j.juro.2008.10.035. Epub 2008 Dec 13.

3.

Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy.

Lughezzani G, Zorn KC, Budäus L, Sun M, Lee DI, Shalhav AL, Zagaya GP, Shikanov SA, Gofrit ON, Thong AE, Albala DM, Sun L, Cronin A, Vickers AJ, Karakiewicz PI.

Eur Urol. 2012 Oct;62(4):590-6. doi: 10.1016/j.eururo.2012.04.022. Epub 2012 May 2.

4.

Calibration of risk prediction models: impact on decision-analytic performance.

Van Calster B, Vickers AJ.

Med Decis Making. 2015 Feb;35(2):162-9. doi: 10.1177/0272989X14547233. Epub 2014 Aug 25.

PMID:
25155798
5.

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.

Vickers AJ, Cronin AM, Elkin EB, Gonen M.

BMC Med Inform Decis Mak. 2008 Nov 26;8:53. doi: 10.1186/1472-6947-8-53.

6.

Using the weighted area under the net benefit curve for decision curve analysis.

Talluri R, Shete S.

BMC Med Inform Decis Mak. 2016 Jul 18;16:94. doi: 10.1186/s12911-016-0336-x.

7.

The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.

Cooperberg MR, Hilton JF, Carroll PR.

Cancer. 2011 Nov 15;117(22):5039-46. doi: 10.1002/cncr.26169. Epub 2011 Jun 3.

8.

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

Gallina A, Chun FK, Briganti A, Shariat SF, Montorsi F, Salonia A, Erbersdobler A, Rigatti P, Valiquette L, Huland H, Graefen M, Karakiewicz PI.

Eur Urol. 2007 Jul;52(1):98-105. Epub 2007 Jan 22.

PMID:
17267098
9.

Comparison of three versions of Partin tables to predict final pathologic stage in a Chinese cohort: a decision curve analysis.

Xiao WJ, Ye DW, Yao XD, Zhang SL, Dai B.

Urol Int. 2013;91(1):69-74. doi: 10.1159/000347186. Epub 2013 Mar 28.

PMID:
23548872
10.

Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.

Abdollah F, Schmitges J, Sun M, Thuret R, Djahangirian O, Tian Z, Shariat SF, Briganti A, Perrotte P, Montorsi F, Karakiewicz PI.

Urology. 2011 Dec;78(6):1363-7. doi: 10.1016/j.urology.2011.07.1423.

PMID:
22137704
11.

Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer.

Okihara K, Kamoi K, Lane RB, Evans RB, Troncoso P, Babaian RJ.

J Clin Ultrasound. 2002 Mar-Apr;30(3):123-31.

PMID:
11948567
12.

Evaluating a new marker for risk prediction: decision analysis to the rescue.

Baker SG, Kramer BS.

Discov Med. 2012 Sep;14(76):181-8. Review.

13.

Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.

Tamblyn DJ, Chopra S, Yu C, Kattan MW, Pinnock C, Kopsaftis T.

BJU Int. 2011 Nov;108 Suppl 2:51-6. doi: 10.1111/j.1464-410X.2011.10687.x.

14.

A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.

Pierorazio PM, Ross AE, Schaeffer EM, Epstein JI, Han M, Walsh PC, Partin AW.

J Urol. 2011 May;185(5):1691-7. doi: 10.1016/j.juro.2010.12.059. Epub 2011 Mar 21.

15.

Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.

Johnson SB, Hamstra DA, Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):275-81. doi: 10.1016/j.ijrobp.2013.05.043. Epub 2013 Jul 23.

PMID:
23886418
16.

Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.

Shariat SF, Savage C, Chromecki TF, Sun M, Scherr DS, Lee RK, Lughezzani G, Remzi M, Marberger MJ, Karakiewicz PI, Vickers AJ.

Cancer. 2011 Jul 1;117(13):2892-7. doi: 10.1002/cncr.25903. Epub 2011 Jan 10.

17.

Characterizing Decision-Analysis Performances of Risk Prediction Models Using ADAPT Curves.

Lee WC, Wu YC.

Medicine (Baltimore). 2016 Jan;95(2):e2477. doi: 10.1097/MD.0000000000002477.

18.

Monte Carlo decision curve analysis using aggregate data.

Hozo I, Tsalatsanis A, Djulbegovic B.

Eur J Clin Invest. 2017 Feb;47(2):176-183. doi: 10.1111/eci.12723.

PMID:
28042671
19.

Evaluation of prognostic factors after radical prostatectomy in pT3b prostate cancer patients in Japanese population.

Inoue T, Kinoshita H, Terada N, Kobayashi T, Yamasaki T, Matsui Y, Kamba T, Inui H, Sugi M, Matsuda T, Ogawa O.

Jpn J Clin Oncol. 2015 Aug;45(8):780-4. doi: 10.1093/jjco/hyv077. Epub 2015 May 15.

PMID:
25981623
20.

Introducing a prognostic score for pretherapeutic assessment of seminal vesicle invasion in patients with clinically localized prostate cancer.

Salomon L, Porcher R, Anastasiadis AG, Levrel O, Saint F, De la Taille A, Vordos D, Cicco A, Hoznek A, Chopin D, Abbou CC, Lagrange JL.

Radiother Oncol. 2003 Jun;67(3):313-9.

PMID:
12865180

Supplemental Content

Support Center